what is glp-1 agonists Comparing Ozempic, Wegovy and Other Drugs Evolution of GLP‐1 Receptor Agonists

New analyses involving more than 100,000 patients suggest that users of popular diabetes and weight-loss medications face a lower risk of developing certain cancers and a reduced risk of metastasis.

Ozempic, Wegovy, Zepbound, and Mounjaro are GLP-1 medications that help lower blood sugar

The Ozempic lawsuit centers on allegations that Novo Nordisk failed to adequately warn consumers about serious risks associated with Ozempic and other GLP-1...

It's classic drug repurposing, a technique that saved lives during COVID.

Sharing what this could mean for you.

The Phase III trial of this pipeline drug for treating type 2 diabetes mellitus, non-alcoholic fatty liver disease, and obesity started on August 28, 2023